Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Matsuda

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Psychopharmacology|October 9, 2017
Response to the letter from Dr. Veerman and colleaguesTaro Kishi, Toshikazu Ikuta, Yuki Matsuda, et al.
Journal of Psychiatric Research|November 8, 2012
Blonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trialsTaro Kishi, Yuki Matsuda, Hiroshi Nakamura, et al.
Inorganic Chemistry|February 19, 2015
Mixed valency in quadruple hydrogen-bonded dimers of bis(biimidazolate)dirhodium complexesJin-Long, Yuki Matsuda, Kazuhiro Uemura, et al.
Acta Crystallographica. Section E, Crystallographic Communications|February 5, 2025
Crystal structures of two polymorphs for <i>fac</i>-bromido-tricarbon-yl[4-(4-meth-oxy-phen-yl)-2-(pyridin-2-yl)thia-zole-κ<sup>2</sup> <i>N</i>,<i>N</i>']rhenium(I)Yuki Matsuda, Ryota Nakamura, Yoshiki Ozawa, et al.
Neuropsychobiology|January 20, 2020
Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled TrialYuki Matsuda, Shinsuke Kito, Yoshio Igarashi, et al.
Human Psychopharmacology|January 16, 2014
A meta-analysis of inositol for depression and anxiety disordersTomohiko Mukai, Taro Kishi, Yuki Matsuda, et al.
Psychiatry and Clinical Neurosciences|March 21, 2020
Thumb twitch during repetitive transcranial magnetic stimulation in a case with medication-resistant depression: A potential role of caffeineRyuichi Yamazaki, Shinsuke Kito, Yuki Matsuda, et al.
Neuropsychiatric Disease and Treatment|October 7, 2014
Early prediction of blonanserin response in Japanese patients with schizophreniaTaro Kishi, Yuki Matsuda, Kiyoshi Fujita, et al.
Psychiatry and Clinical Neurosciences|July 9, 2026
Model choice in meta-analysis should not be driven by Cochran's Q testYuki Matsuda, Yuta Suzuki, Aran Tajika, et al.
Asian Journal of Psychiatry|December 20, 2021
A 12-month maintenance therapy using repetitive transcranial magnetic stimulation for Treatment-resistant Depression: A report of two casesYuki Matsuda, Ryuichi Yamazaki, Masahiro Shigeta, et al.
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Psychopharmacology|October 9, 2017
Response to the letter from Dr. Veerman and colleaguesTaro Kishi, Toshikazu Ikuta, Yuki Matsuda, et al.
Journal of Psychiatric Research|November 8, 2012
Blonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trialsTaro Kishi, Yuki Matsuda, Hiroshi Nakamura, et al.
Inorganic Chemistry|February 19, 2015
Mixed valency in quadruple hydrogen-bonded dimers of bis(biimidazolate)dirhodium complexesJin-Long, Yuki Matsuda, Kazuhiro Uemura, et al.
Acta Crystallographica. Section E, Crystallographic Communications|February 5, 2025
Crystal structures of two polymorphs for <i>fac</i>-bromido-tricarbon-yl[4-(4-meth-oxy-phen-yl)-2-(pyridin-2-yl)thia-zole-κ<sup>2</sup> <i>N</i>,<i>N</i>']rhenium(I)Yuki Matsuda, Ryota Nakamura, Yoshiki Ozawa, et al.
Neuropsychobiology|January 20, 2020
Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled TrialYuki Matsuda, Shinsuke Kito, Yoshio Igarashi, et al.
Human Psychopharmacology|January 16, 2014
A meta-analysis of inositol for depression and anxiety disordersTomohiko Mukai, Taro Kishi, Yuki Matsuda, et al.
Psychiatry and Clinical Neurosciences|March 21, 2020
Thumb twitch during repetitive transcranial magnetic stimulation in a case with medication-resistant depression: A potential role of caffeineRyuichi Yamazaki, Shinsuke Kito, Yuki Matsuda, et al.
Neuropsychiatric Disease and Treatment|October 7, 2014
Early prediction of blonanserin response in Japanese patients with schizophreniaTaro Kishi, Yuki Matsuda, Kiyoshi Fujita, et al.
Psychiatry and Clinical Neurosciences|July 9, 2026
Model choice in meta-analysis should not be driven by Cochran's Q testYuki Matsuda, Yuta Suzuki, Aran Tajika, et al.
Asian Journal of Psychiatry|December 20, 2021
A 12-month maintenance therapy using repetitive transcranial magnetic stimulation for Treatment-resistant Depression: A report of two casesYuki Matsuda, Ryuichi Yamazaki, Masahiro Shigeta, et al.
Pageof 13